Rapport therapeutics to present at 22nd annual morgan stanley global healthcare conference and td cowen's 4th annual novel mechanisms in neuropsychiatry summit

Boston and san diego, aug. 29, 2024 (globe newswire) -- rapport therapeutics, inc. (nasdaq: rapp), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system (cns) disorders, today announced that management will present at two upcoming investor conferences:
RAPP Ratings Summary
RAPP Quant Ranking